nodes	percent_of_prediction	percent_of_DWPC	metapath
Debrisoquin—ABCB1—Mitomycin—urinary bladder cancer	0.402	0.474	CbGbCtD
Debrisoquin—ABCB1—Gemcitabine—urinary bladder cancer	0.116	0.136	CbGbCtD
Debrisoquin—ABCB1—Cisplatin—urinary bladder cancer	0.0841	0.0991	CbGbCtD
Debrisoquin—ABCB1—Etoposide—urinary bladder cancer	0.0827	0.0974	CbGbCtD
Debrisoquin—ABCB1—Doxorubicin—urinary bladder cancer	0.0564	0.0664	CbGbCtD
Debrisoquin—ABCB1—Methotrexate—urinary bladder cancer	0.0546	0.0643	CbGbCtD
Debrisoquin—CYP2D6—Doxorubicin—urinary bladder cancer	0.0531	0.0626	CbGbCtD
Debrisoquin—ABCB1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00925	0.0614	CbGpPWpGaD
Debrisoquin—CYP2D6—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00872	0.0578	CbGpPWpGaD
Debrisoquin—SLC6A2—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.00798	0.0529	CbGpPWpGaD
Debrisoquin—CYP1A1—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00606	0.0402	CbGpPWpGaD
Debrisoquin—CYP2D6—Miscellaneous substrates—CYP4B1—urinary bladder cancer	0.00568	0.0377	CbGpPWpGaD
Debrisoquin—CYP1A1—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00535	0.0355	CbGpPWpGaD
Debrisoquin—CYP2D6—Fatty acids—CYP4B1—urinary bladder cancer	0.00475	0.0315	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00434	0.0288	CbGpPWpGaD
Debrisoquin—CYP2D6—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00403	0.0267	CbGpPWpGaD
Debrisoquin—CYP2D6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00327	0.0217	CbGpPWpGaD
Debrisoquin—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00312	0.0207	CbGpPWpGaD
Debrisoquin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00262	0.0174	CbGpPWpGaD
Debrisoquin—CYP1A1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00241	0.016	CbGpPWpGaD
Debrisoquin—CYP1A1—Estrogen metabolism—NQO1—urinary bladder cancer	0.00234	0.0155	CbGpPWpGaD
Debrisoquin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00208	0.0138	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00206	0.0137	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00205	0.0136	CbGpPWpGaD
Debrisoquin—CYP1A1—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.00183	0.0121	CbGpPWpGaD
Debrisoquin—CYP1A1—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00179	0.0119	CbGpPWpGaD
Debrisoquin—CYP1A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00169	0.0112	CbGpPWpGaD
Debrisoquin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00157	0.0104	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidative Stress—NQO1—urinary bladder cancer	0.00155	0.0103	CbGpPWpGaD
Debrisoquin—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00155	0.0103	CbGpPWpGaD
Debrisoquin—SLC6A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00142	0.00941	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.00137	0.00908	CbGpPWpGaD
Debrisoquin—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00134	0.0089	CbGpPWpGaD
Debrisoquin—CYP1A1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00128	0.0085	CbGpPWpGaD
Debrisoquin—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00127	0.00842	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidative Stress—SOD2—urinary bladder cancer	0.0012	0.00793	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00115	0.00761	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidative Stress—GPX1—urinary bladder cancer	0.00114	0.00756	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00113	0.00751	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.0011	0.00732	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.0011	0.00732	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00109	0.00722	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—NAT1—urinary bladder cancer	0.00109	0.00722	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00107	0.00712	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000995	0.0066	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000982	0.00651	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000896	0.00594	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000884	0.00586	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000864	0.00573	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000852	0.00565	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000819	0.00543	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000819	0.00543	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000808	0.00536	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—NQO1—urinary bladder cancer	0.000795	0.00527	CbGpPWpGaD
Debrisoquin—SLC6A2—Monoamine Transport—TNF—urinary bladder cancer	0.000781	0.00518	CbGpPWpGaD
Debrisoquin—CYP1A1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000758	0.00503	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000749	0.00497	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000745	0.00494	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000739	0.0049	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000721	0.00478	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000675	0.00447	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000665	0.00441	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000664	0.00441	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—GSTP1—urinary bladder cancer	0.000663	0.0044	CbGpPWpGaD
Debrisoquin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000617	0.00409	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—GSTM1—urinary bladder cancer	0.000609	0.00404	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—NAT2—urinary bladder cancer	0.000596	0.00396	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000588	0.0039	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.00058	0.00385	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000521	0.00346	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000477	0.00316	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.000477	0.00316	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000462	0.00307	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000459	0.00305	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000449	0.00298	CbGpPWpGaD
Debrisoquin—CYP1A1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000446	0.00296	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000446	0.00296	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000443	0.00294	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000442	0.00293	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000425	0.00282	CbGpPWpGaD
Debrisoquin—CYP1A1—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.000421	0.00279	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000417	0.00276	CbGpPWpGaD
Debrisoquin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000412	0.00273	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000397	0.00263	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000397	0.00263	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000393	0.00261	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000386	0.00256	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000386	0.00256	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000359	0.00238	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00035	0.00232	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000348	0.00231	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000348	0.00231	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000348	0.00231	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000346	0.00229	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000344	0.00228	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000338	0.00224	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000338	0.00224	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000322	0.00214	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000322	0.00214	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00032	0.00213	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000319	0.00212	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000317	0.00211	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000316	0.0021	CbGpPWpGaD
Debrisoquin—CYP1A1—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000302	0.002	CbGpPWpGaD
Debrisoquin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000295	0.00196	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000295	0.00195	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00029	0.00193	CbGpPWpGaD
Debrisoquin—CYP1A1—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.00029	0.00192	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000287	0.0019	CbGpPWpGaD
Debrisoquin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000284	0.00188	CbGpPWpGaD
Debrisoquin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000284	0.00188	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00028	0.00186	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000271	0.0018	CbGpPWpGaD
Debrisoquin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000262	0.00174	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000241	0.0016	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.00024	0.00159	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000238	0.00158	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000237	0.00157	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000229	0.00152	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000229	0.00152	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000223	0.00148	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000222	0.00147	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000219	0.00145	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000219	0.00145	CbGpPWpGaD
Debrisoquin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000204	0.00135	CbGpPWpGaD
Debrisoquin—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	0.000197	0.00131	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	0.000196	0.0013	CbGpPWpGaD
Debrisoquin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000196	0.0013	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000194	0.00129	CbGpPWpGaD
Debrisoquin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000193	0.00128	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000187	0.00124	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—NAT1—urinary bladder cancer	0.000186	0.00123	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	0.000186	0.00123	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000183	0.00121	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000171	0.00114	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000171	0.00113	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	0.00017	0.00113	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00017	0.00113	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	0.000167	0.00111	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	0.000157	0.00104	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	0.000153	0.00102	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000149	0.000988	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	0.000149	0.000986	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—NAT1—urinary bladder cancer	0.000149	0.000986	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000148	0.00098	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000147	0.000975	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	0.000145	0.00096	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	0.000141	0.000936	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.00014	0.000929	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.00014	0.000929	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	0.000136	0.000902	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000134	0.000891	CbGpPWpGaD
Debrisoquin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000133	0.000883	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.000128	0.00085	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000126	0.000838	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000125	0.000827	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	0.000122	0.000812	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000122	0.000809	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	0.000116	0.000767	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	0.000115	0.000765	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000113	0.00075	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—TYMP—urinary bladder cancer	0.000113	0.000748	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	0.000113	0.000747	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.00011	0.000731	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	0.000109	0.000723	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000108	0.000718	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000107	0.000707	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000106	0.000705	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	0.000106	0.000704	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—NAT2—urinary bladder cancer	0.000102	0.000676	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000101	0.000673	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.86e-05	0.000654	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—TYMP—urinary bladder cancer	9.01e-05	0.000597	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.84e-05	0.000586	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—RRM2—urinary bladder cancer	8.8e-05	0.000584	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.64e-05	0.000573	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	8.49e-05	0.000563	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	8.23e-05	0.000546	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.17e-05	0.000542	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—ENO2—urinary bladder cancer	8.15e-05	0.000541	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	8.15e-05	0.000541	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—NAT2—urinary bladder cancer	8.14e-05	0.00054	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.1e-05	0.000538	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	7.91e-05	0.000524	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.79e-05	0.000516	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	7.68e-05	0.000509	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.26e-05	0.000481	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—RRM2—urinary bladder cancer	7.03e-05	0.000466	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	6.63e-05	0.000439	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—NQO1—urinary bladder cancer	6.57e-05	0.000436	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—ENO2—urinary bladder cancer	6.51e-05	0.000432	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	6.51e-05	0.000432	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.38e-05	0.000423	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	6.32e-05	0.000419	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	6.14e-05	0.000407	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	6.14e-05	0.000407	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.95e-05	0.000395	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.91e-05	0.000392	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.56e-05	0.000369	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	5.48e-05	0.000364	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.3e-05	0.000352	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—NQO1—urinary bladder cancer	5.25e-05	0.000348	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—TYMS—urinary bladder cancer	5.1e-05	0.000338	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	5.04e-05	0.000334	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	5.04e-05	0.000334	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.95e-05	0.000328	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GPX1—urinary bladder cancer	4.82e-05	0.00032	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	4.74e-05	0.000314	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	4.45e-05	0.000295	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	4.38e-05	0.00029	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	4.13e-05	0.000274	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—TYMS—urinary bladder cancer	4.07e-05	0.00027	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	4.02e-05	0.000267	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	4.02e-05	0.000267	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.85e-05	0.000256	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.83e-05	0.000254	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.79e-05	0.000251	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.79e-05	0.000251	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.78e-05	0.000251	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.63e-05	0.000241	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—PPARG—urinary bladder cancer	3.61e-05	0.000239	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.56e-05	0.000236	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	3.56e-05	0.000236	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	3.47e-05	0.00023	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.35e-05	0.000222	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.88e-05	0.000191	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	2.84e-05	0.000188	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.77e-05	0.000184	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.72e-05	0.00018	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.61e-05	0.000173	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—PTEN—urinary bladder cancer	2.48e-05	0.000164	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—EP300—urinary bladder cancer	2.36e-05	0.000157	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.27e-05	0.00015	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.14e-05	0.000142	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.98e-05	0.000131	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—EP300—urinary bladder cancer	1.89e-05	0.000125	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.86e-05	0.000124	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.78e-05	0.000118	CbGpPWpGaD
